Elite Pharmaceuticals Inc  

(Public, OTCMKTS:ELTP)   Watch this stock  
Find more results for elites
-0.0029 (-3.09%)
Oct 23 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.09 - 0.09
52 week 0.09 - 0.25
Open 0.09
Vol / Avg. 349,141.00/790,020.00
Mkt cap 70.36M
P/E 3.30
Div/yield     -
EPS 0.03
Shares 781.74M
Beta -0.15
Inst. own 0%
Nov 7, 2017
Q2 2018 Elite Pharmaceuticals Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Aug 10, 2017
Q1 2018 Elite Pharmaceuticals Inc Earnings Call
Aug 9, 2017
Q1 2018 Elite Pharmaceuticals Inc Earnings Release

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin -127.37% 39.54%
Operating margin -131.45% -76.32%
EBITD margin - -68.91%
Return on average assets -25.51% 11.55%
Return on average equity -59.09% -
Employees 46 -
CDP Score - -


165 Ludlow Ave
NORTHVALE, NJ 07647-2305
United States - Map
+1-201-7502646 (Phone)
+1-201-7502755 (Fax)

Website links


Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company develops and manufactures generic products, products using controlled-release drug technology, products utilizing abuse deterrent technologies, and it develops and markets generic controlled-release and abuse deterrent pharmaceutical products. Its segments include Abbreviated New Drug Applications (ANDA's) for generic products and New Drug Applications (NDA's) for branded products. The Company owns approximately six different approved ANDA's. The Company's product, SequestOx, is an immediate-release Oxycodone Hydrochloride containing sequestered Naltrexone, which incorporates five milligram, 10 milligram, 15 milligram, 20 milligram and 30 milligram doses of oxycodone into capsules. SequestOx is used for the management of moderate to severe pain where the use of an opioid analgesic is appropriate.

Officers and directors

Nasrat Hakim Chairman of the Board, President, Chief Executive Officer
Age: 53
Jerry I. Treppel Chairman of the Board
Age: 60
Carter Julian Ward CPA Chief Financial Officer, Treasurer, Secretary
Age: 51
Douglas Plassche Executive Vice President - Operations
Age: 52
Ashok G. Nigalaye Ph.D. Chief Scientific Officer, Director
Age: 62
George Kenneth Smith Vice President
Davis S. Caskey Director
Age: 65
Jeenarine Narine Director
Age: 64
Eugene M. Pfeifer Director
Age: 76
Barry H. Dash Ph.D. Independent Director
Age: 84